Exaggerated blood pressure response to standing in young-to-middle-age subjects: prevalence and factors involved.
Ambulatory
Epinephrine
Orthostatic
Reactivity
Standing
White-coat effect
Journal
Clinical autonomic research : official journal of the Clinical Autonomic Research Society
ISSN: 1619-1560
Titre abrégé: Clin Auton Res
Pays: Germany
ID NLM: 9106549
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
03
03
2023
accepted:
04
04
2023
medline:
21
8
2023
pubmed:
29
4
2023
entrez:
29
4
2023
Statut:
ppublish
Résumé
To investigate the prevalence of orthostatic hypertension and the association of the blood pressure (BP) level, supine BP decline, and white-coat effect with the orthostatic pressor response. We studied 1275 young-to-middle-age individuals with stage-1 hypertension. Orthostatic response was assessed three times over a 3 month period. The white-coat effect was assessed at baseline and after 3 months, and was calculated as the difference between office and average 24 h BP. In 660 participants, urinary epinephrine and norepinephrine were also measured. An orthostatic systolic BP increase ≥ 20 mmHg was observed in 0.6-1.2% of the subjects during the three visits. Using the 20 mmHg cut-off, the prevalence of orthostatic hypertension was 0.6%. An orthostatic BP increase of ≥ 5 mmHg was found in 14.4% of participants. At baseline, the orthostatic response to standing showed an independent negative association with the supine BP level (p < 0.001), the supine BP change from the first to third measurement (p < 0.001), and the white-coat effect (p < 0.001). Similar results were obtained in the 1080 participants assessed at the third visit. Urinary epinephrine showed higher values in the top BP response decile (systolic BP increase ≥ 6 mmHg, p = 0.002 versus rest of the group). An orthostatic systolic BP reaction ≥ 20 mmHg is rare in young adults. However, even lower BP increases may be clinically relevant. The BP level, the supine BP decline over repeated measurement, and the white-coat effect can influence the estimate of the BP response to standing and should be considered in clinical and pathogenetic studies.
Identifiants
pubmed: 37119425
doi: 10.1007/s10286-023-00942-0
pii: 10.1007/s10286-023-00942-0
pmc: PMC10439022
doi:
Substances chimiques
Epinephrine
YKH834O4BH
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
391-399Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023. The Author(s).
Références
J Hypertens. 2016 Jun;34(6):1068-74
pubmed: 27032073
J Hypertens. 2007 Jul;25(7):1327-36
pubmed: 17563549
Circulation. 1994 Dec;90(6):2870-6
pubmed: 7994832
Acta Physiol Scand. 1975 May;94(1):139-41
pubmed: 1155162
Int J Epidemiol. 2005 Feb;34(1):215-20
pubmed: 15333621
Hypertens Res. 2004 Apr;27(4):235-41
pubmed: 15127880
J Hypertens. 2022 Oct 1;40(10):1927-1934
pubmed: 36052521
Hypertension. 2016 Oct;68(4):888-95
pubmed: 27504006
J Hypertens. 2006 Aug;24(8):1479-87
pubmed: 16877948
Stroke. 1997 Nov;28(11):2169-73
pubmed: 9368559
Int J Endocrinol. 2015;2015:463487
pubmed: 26078756
Clin Auton Res. 2023 Feb;33(1):69-73
pubmed: 36173501
J Clin Hypertens (Greenwich). 2019 Mar;21(3):426-433
pubmed: 30724451
J Geriatr Cardiol. 2016 Mar;13(3):239-43
pubmed: 27103919
Clin Auton Res. 2023 Feb;33(1):29-40
pubmed: 36473959
J Hum Hypertens. 2019 Oct;33(10):735-740
pubmed: 30804464
Hypertension. 1985 Mar-Apr;7(2):196-203
pubmed: 3980066
J Am Coll Cardiol. 2002 Jul 3;40(1):133-41
pubmed: 12103267
J Am Soc Hypertens. 2016 Nov;10(11):847-856
pubmed: 27665708
Hypertension. 1999 Jan;33(1):36-43
pubmed: 9931079
Hypertension. 2016 Jan;67(1):191-6
pubmed: 26597824
Mayo Clin Proc. 2003 Aug;78(8):951-8
pubmed: 12911043
Am J Hypertens. 2015 Oct;28(10):1248-56
pubmed: 25767137
J Diabetes Complications. 2009 Mar-Apr;23(2):83-8
pubmed: 18413171
Am J Hypertens. 2010 Aug;23(8):829-37
pubmed: 20414196
Br J Pharmacol. 1981 Jul;73(3):669-79
pubmed: 6113865
Hypertens Res. 2005 Jan;28(1):15-9
pubmed: 15969250
Hypertension. 2022 May;79(5):984-992
pubmed: 35296159
J Hypertens. 2000 Jun;18(6):769-75
pubmed: 10872563
Hypertens Res. 2008 May;31(5):897-904
pubmed: 18712045
Hypertension. 2020 May;75(5):1151-1158
pubmed: 32223382
Am J Med. 1997 Sep;103(3):208-16
pubmed: 9316553
J Clin Hypertens (Greenwich). 2017 Dec;19(12):1357-1365
pubmed: 28929576
Hypertension. 1998 Jan;31(1):77-82
pubmed: 9449395
J Hypertens. 2021 Jul 1;39(7):1293-1302
pubmed: 33710173
Front Physiol. 2014 Mar 04;5:86
pubmed: 24624092
Hypertension. 2000 Feb;35(2):614-20
pubmed: 10679506
Kidney Int. 2006 Aug;70(3):578-84
pubmed: 16788693
Diagnostics (Basel). 2023 Jan 25;13(3):
pubmed: 36766538
Blood Press Monit. 2017 Aug;22(4):184-190
pubmed: 28263203
Hypertension. 1994 Feb;23(2):211-6
pubmed: 8307631
Hypertens Res. 2008 Aug;31(8):1509-16
pubmed: 18971524
J Clin Hypertens (Greenwich). 2019 Jul;21(7):877-883
pubmed: 31215143
Cardiovasc Diabetol. 2016 Jun 02;15:83
pubmed: 27255168